D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 78,900
-5,000 (-5.96%)
Mar 9, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.43 trillion as of March 9, 2026. Its market cap has increased by 523.86% in one year.
Market Cap
3.43T
Enterprise Value
3.40T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
78,900.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.43T, an increase of 804.98%. That is a compound annual growth rate of 230.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3,652.62B | -8.61% |
| Dec 30, 2025 | 3,996.55B | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResearch | 3,459.75B |
| SK bioscience | 3,431.52B |
| OliX Pharmaceuticals | 4,179.31B |
| Hugel | 2,824.54B |
| Orum Therapeutics | 2,490.56B |
| Voronoi | 5,927.74B |
| Peptron | 6,132.46B |
| HLB Co., Ltd. | 6,749.36B |